key: cord-0956823-2d2nhaex authors: Subramanian, Vijay; Anderson, Christopher; Karp, Seth; Pastan, Stephen; Gerber, David; Locke, Jayme; Cohen, Ari; Shah, Malay; Casingal, Vincent; Strata, Robert; Singh, Neeraj; DuBay, Derek; Dhanireddy, Kiran title: COVID‐19 and transplantation—Data censoring date: 2022-04-28 journal: Am J Transplant DOI: 10.1111/ajt.17065 sha: e7bae92317972649458789f238ecfddedd7f7393 doc_id: 956823 cord_uid: 2d2nhaex During the early wave of the COVID‐19 pandemic, the Scientific Registry of Transplant Recipients (SRTR) designated a “black out” period between March 12, 2020, and June 12, 2020, for transplant outcomes reporting. We discuss the implications and potential bias it has introduced as it may selectively favor the outcomes for certain regions and harm other regions due to varied effects of different waves of COVID‐19 infections across the United States. During the early wave of the COVID-19 pandemic, the Scientific Registry of Transplant Recipients (SRTR) designated a "black out" period between March 12, 2020, and June 12, 2020, for transplant outcomes reporting. We discuss the implications and potential bias it has introduced as it may selectively favor the outcomes for certain regions and harm other regions due to varied effects of different waves of COVID-19 infections across the United States. editorial/personal viewpoint, ethics and public policy, law/legislation, organ transplantation in general, patient survival, Scientific Registry for Transplant Recipients (SRTR) disappeared into this "black hole" following that date and those transplanted between March 12, 2020, and June 12, 2020, were considered to not exist for the purpose of transplant data metrics and analysis. 4 This period was chosen because it reflected the first wave or peak of COVID-19 infections. At that time, it was unclear how the COVID-19 infection would affect transplant center metrics directly due to changes in transplant center practice and indirectly due to COVID-19 cases in the community. Several methods were implemented to curtail the pandemic such as contact tracing, lock downs, mask requirements, hand hygiene, and social distancing. Better understanding of the virus and its pathogenesis has led to vaccines and novel therapeutics such as targeted antibody and antiviral therapies. Despite these efforts, the virus continues to circulate in our communities. Several viral variants have emerged in the past 2 years causing "surges/waves" in case numbers and mortality. 5 In summary, the SRTR has potentially introduced bias into riskadjusted performance outcomes reporting that unintentionally favors certain geographies and populations. We believe the decision by the SRTR to only censor the period corresponding to the first COVID-19 wave creates a disparity for centers in regions outside the Northeast as they were less impacted by this wave. The SRTR committee decided that reporting of metrics would return to normal, and the period of data censoring would be a "black hole period" as the calculation of organ-specific metrics would not be uniform. They did note that the intent of data censoring was only for the risk- into consideration. Hence, we disagree with the SRTR's stance that the risks of bias were minimal, as we are unsure of how the different metrics were impacted by COVID-19 waves. 4 We believe that a critical review of these effects is essential prior to any data reporting or censoring that could affect all transplant centers differently. We are proposing two potential solutions to address data censoring inequity: 1. Censoring all data during significant COVID-19 waves from the beginning of the pandemic irrespective of location or timing. 2. Collecting the data but halt all public reporting of data until the full impact of the pandemic is understood. Once sufficient data are analyzed and accounted for, prior to data reporting, it would be essential to include COVID-19 infection into the risk calculation, particularly with respect to deaths or outcomes directly or indirectly attributed to COVID-19. The SRTR is not required to seek public comment on changes in data reporting or censoring. Due to the extraordinary circumstances of the pandemic, we also believe that an opportunity for public comment is necessary to allow for all perspectives to be represented in a critical decision that impacts every transplant program differently. We acknowledge that the data discussed in this paper are acquired from public databases with intrinsic bias and do not necessarily reflect the exact circumstance of transplant patients. Nevertheless, extrapolating population-based data to transplant patients is justifiable since these dynamics significantly impact transplant centers in numerous ways. 11 Medical professionals including transplant teams have been under immense stress to continue to perform at high level and provide care for severely ill patients. It is critical to the transplant community that the SRTR maintains integrity in data and equity in reporting. Transplant programs should not suffer lower performance measurements secondary to potentially biased and inequitable censoring of data. The authors of thismanuscript have no conflicts of interest to disclose as described by the American Journal of Transplantation. The data that support the findings of this study are openly available in CDC, SRTR, OPTN, WHO databases -References 1, 2, 4, 6 in the manuscript. https://orcid.org/0000-0003-2469-3094 Seth Karp https://orcid.org/0000-0002-5266-1025 Stephen Pastan https://orcid.org/0000-0003-2638-6354 Jayme Locke https://orcid.org/0000-0002-0220-8716 Malay Shah https://orcid.org/0000-0001-5325-2410 Robert Strata https://orcid.org/0000-0001-7634-094X WHO. WHO Coronavirus (COVID-19) Dashboard. Accessed The socio-economic implications of the coronavirus pandemic (COVID-19): a review Clinical and virological features of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2) variants of concern: a retrospective UNOS regions map (Alpha), B.1.351 (Beta), and B.1.617.2 (Delta) Early impact of COVID-19 on transplant center practices and policies in the United States Navigating the COVID-19 pandemic: Initial impacts and responses of the Organ Procurement and Transplantation Network in the United States COVID-19: a global transplant perspective on successfully navigating a pandemic Pandemic precarity: COVID-19 is exposing and exacerbating inequalities in the American heartland COVID-19-associated mortality among kidney transplant recipients and candidates in the United States COVID-19 and transplantation-Data censoring